nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—PLA2G4A—Epirubicin—sarcoma	0.876	1	CbGbCtD
Carbachol—Abdominal cramps—Vincristine—sarcoma	0.00275	0.0254	CcSEcCtD
Carbachol—Necrosis—Dactinomycin—sarcoma	0.00265	0.0245	CcSEcCtD
Carbachol—CHRM3—muscle of abdomen—sarcoma	0.00262	0.311	CbGeAlD
Carbachol—Extravasation—Thiotepa—sarcoma	0.0024	0.0222	CcSEcCtD
Carbachol—Extravasation—Dactinomycin—sarcoma	0.00238	0.022	CcSEcCtD
Carbachol—Necrosis—Mitoxantrone—sarcoma	0.00231	0.0213	CcSEcCtD
Carbachol—Ulcer—Dactinomycin—sarcoma	0.0022	0.0203	CcSEcCtD
Carbachol—Extravasation—Vincristine—sarcoma	0.00213	0.0197	CcSEcCtD
Carbachol—Extravasation—Mitoxantrone—sarcoma	0.00207	0.0192	CcSEcCtD
Carbachol—Necrosis—Etoposide—sarcoma	0.00192	0.0177	CcSEcCtD
Carbachol—Ulcer—Mitoxantrone—sarcoma	0.00191	0.0177	CcSEcCtD
Carbachol—Hyperkalaemia—Mitoxantrone—sarcoma	0.00178	0.0164	CcSEcCtD
Carbachol—Phlebitis—Dactinomycin—sarcoma	0.00175	0.0162	CcSEcCtD
Carbachol—Extravasation—Etoposide—sarcoma	0.00173	0.0159	CcSEcCtD
Carbachol—Ulcer—Etoposide—sarcoma	0.00159	0.0147	CcSEcCtD
Carbachol—Venous thrombosis—Epirubicin—sarcoma	0.00156	0.0144	CcSEcCtD
Carbachol—Phlebitis—Mitoxantrone—sarcoma	0.00153	0.0141	CcSEcCtD
Carbachol—Venous thrombosis—Doxorubicin—sarcoma	0.00145	0.0134	CcSEcCtD
Carbachol—Hyponatraemia—Vincristine—sarcoma	0.00135	0.0125	CcSEcCtD
Carbachol—Hyponatraemia—Mitoxantrone—sarcoma	0.00132	0.0122	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Mitoxantrone—sarcoma	0.00131	0.0121	CcSEcCtD
Carbachol—Phlebitis—Etoposide—sarcoma	0.00127	0.0117	CcSEcCtD
Carbachol—CHRNA2—mammary gland—sarcoma	0.00115	0.137	CbGeAlD
Carbachol—Sweating increased—Mitoxantrone—sarcoma	0.00111	0.0102	CcSEcCtD
Carbachol—Necrosis—Epirubicin—sarcoma	0.00108	0.00993	CcSEcCtD
Carbachol—Abscess—Epirubicin—sarcoma	0.00107	0.00985	CcSEcCtD
Carbachol—Stinging—Epirubicin—sarcoma	0.00104	0.00962	CcSEcCtD
Carbachol—Sweating—Vincristine—sarcoma	0.000997	0.00921	CcSEcCtD
Carbachol—Necrosis—Doxorubicin—sarcoma	0.000995	0.00919	CcSEcCtD
Carbachol—Abscess—Doxorubicin—sarcoma	0.000987	0.00912	CcSEcCtD
Carbachol—Cramp muscle—Etoposide—sarcoma	0.000984	0.00909	CcSEcCtD
Carbachol—Sweating—Mitoxantrone—sarcoma	0.000971	0.00897	CcSEcCtD
Carbachol—Flushing—Dactinomycin—sarcoma	0.00097	0.00896	CcSEcCtD
Carbachol—Extravasation—Epirubicin—sarcoma	0.000967	0.00894	CcSEcCtD
Carbachol—Stinging—Doxorubicin—sarcoma	0.000964	0.00891	CcSEcCtD
Carbachol—Arrhythmia—Thiotepa—sarcoma	0.00094	0.00869	CcSEcCtD
Carbachol—Sweating increased—Etoposide—sarcoma	0.00092	0.0085	CcSEcCtD
Carbachol—Extravasation—Doxorubicin—sarcoma	0.000895	0.00827	CcSEcCtD
Carbachol—Ulcer—Epirubicin—sarcoma	0.000892	0.00824	CcSEcCtD
Carbachol—Hyperkalaemia—Epirubicin—sarcoma	0.000829	0.00766	CcSEcCtD
Carbachol—Ulcer—Doxorubicin—sarcoma	0.000826	0.00763	CcSEcCtD
Carbachol—Salivary hypersecretion—Epirubicin—sarcoma	0.00082	0.00757	CcSEcCtD
Carbachol—Arrhythmia—Mitoxantrone—sarcoma	0.000812	0.0075	CcSEcCtD
Carbachol—Hyperkalaemia—Doxorubicin—sarcoma	0.000767	0.00709	CcSEcCtD
Carbachol—Salivary hypersecretion—Doxorubicin—sarcoma	0.000758	0.00701	CcSEcCtD
Carbachol—Infection—Thiotepa—sarcoma	0.000743	0.00686	CcSEcCtD
Carbachol—Infection—Dactinomycin—sarcoma	0.000737	0.00681	CcSEcCtD
Carbachol—Phlebitis—Epirubicin—sarcoma	0.000711	0.00657	CcSEcCtD
Carbachol—Flushing—Etoposide—sarcoma	0.000702	0.00648	CcSEcCtD
Carbachol—PLA2G4A—myometrium—sarcoma	0.000662	0.0787	CbGeAlD
Carbachol—Infection—Vincristine—sarcoma	0.000659	0.00609	CcSEcCtD
Carbachol—Dyspepsia—Thiotepa—sarcoma	0.000658	0.00608	CcSEcCtD
Carbachol—Phlebitis—Doxorubicin—sarcoma	0.000658	0.00608	CcSEcCtD
Carbachol—Infection—Mitoxantrone—sarcoma	0.000642	0.00593	CcSEcCtD
Carbachol—Hyperhidrosis—Vincristine—sarcoma	0.000641	0.00592	CcSEcCtD
Carbachol—Pain—Thiotepa—sarcoma	0.00064	0.00591	CcSEcCtD
Carbachol—Shock—Mitoxantrone—sarcoma	0.000635	0.00587	CcSEcCtD
Carbachol—Pain—Dactinomycin—sarcoma	0.000635	0.00586	CcSEcCtD
Carbachol—Muscle spasms—Etoposide—sarcoma	0.000633	0.00585	CcSEcCtD
Carbachol—Hyperhidrosis—Mitoxantrone—sarcoma	0.000624	0.00577	CcSEcCtD
Carbachol—Hypotension—Vincristine—sarcoma	0.00062	0.00572	CcSEcCtD
Carbachol—Hyponatraemia—Epirubicin—sarcoma	0.000615	0.00568	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000613	0.00566	CcSEcCtD
Carbachol—Hypotension—Mitoxantrone—sarcoma	0.000604	0.00558	CcSEcCtD
Carbachol—PLA2G4A—seminal vesicle—sarcoma	0.000598	0.0711	CbGeAlD
Carbachol—Body temperature increased—Thiotepa—sarcoma	0.000591	0.00546	CcSEcCtD
Carbachol—Abdominal pain—Thiotepa—sarcoma	0.000591	0.00546	CcSEcCtD
Carbachol—Abdominal pain—Dactinomycin—sarcoma	0.000587	0.00542	CcSEcCtD
Carbachol—Body temperature increased—Dactinomycin—sarcoma	0.000587	0.00542	CcSEcCtD
Carbachol—Loss of consciousness—Etoposide—sarcoma	0.000579	0.00534	CcSEcCtD
Carbachol—Hyponatraemia—Doxorubicin—sarcoma	0.000569	0.00526	CcSEcCtD
Carbachol—Dyspepsia—Mitoxantrone—sarcoma	0.000569	0.00525	CcSEcCtD
Carbachol—PLA2G4A—hematopoietic system—sarcoma	0.000568	0.0676	CbGeAlD
Carbachol—Pain—Vincristine—sarcoma	0.000567	0.00524	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000567	0.00524	CcSEcCtD
Carbachol—Pain—Mitoxantrone—sarcoma	0.000552	0.0051	CcSEcCtD
Carbachol—PLA2G4A—connective tissue—sarcoma	0.000547	0.0651	CbGeAlD
Carbachol—Infection—Etoposide—sarcoma	0.000534	0.00493	CcSEcCtD
Carbachol—Asthma—Epirubicin—sarcoma	0.00053	0.00489	CcSEcCtD
Carbachol—Abdominal pain—Vincristine—sarcoma	0.000524	0.00484	CcSEcCtD
Carbachol—Body temperature increased—Vincristine—sarcoma	0.000524	0.00484	CcSEcCtD
Carbachol—Hyperhidrosis—Etoposide—sarcoma	0.000519	0.0048	CcSEcCtD
Carbachol—Diarrhoea—Thiotepa—sarcoma	0.000512	0.00473	CcSEcCtD
Carbachol—Abdominal pain—Mitoxantrone—sarcoma	0.000511	0.00472	CcSEcCtD
Carbachol—Body temperature increased—Mitoxantrone—sarcoma	0.000511	0.00472	CcSEcCtD
Carbachol—Diarrhoea—Dactinomycin—sarcoma	0.000508	0.00469	CcSEcCtD
Carbachol—Hypotension—Etoposide—sarcoma	0.000502	0.00464	CcSEcCtD
Carbachol—PLA2G4A—smooth muscle tissue—sarcoma	0.0005	0.0595	CbGeAlD
Carbachol—Dizziness—Thiotepa—sarcoma	0.000495	0.00457	CcSEcCtD
Carbachol—Asthma—Doxorubicin—sarcoma	0.00049	0.00453	CcSEcCtD
Carbachol—Vomiting—Thiotepa—sarcoma	0.000476	0.00439	CcSEcCtD
Carbachol—Vomiting—Dactinomycin—sarcoma	0.000472	0.00436	CcSEcCtD
Carbachol—Rash—Thiotepa—sarcoma	0.000472	0.00436	CcSEcCtD
Carbachol—Dermatitis—Thiotepa—sarcoma	0.000471	0.00435	CcSEcCtD
Carbachol—Headache—Thiotepa—sarcoma	0.000469	0.00433	CcSEcCtD
Carbachol—Rash—Dactinomycin—sarcoma	0.000468	0.00432	CcSEcCtD
Carbachol—Pain—Etoposide—sarcoma	0.000459	0.00424	CcSEcCtD
Carbachol—Diarrhoea—Vincristine—sarcoma	0.000454	0.00419	CcSEcCtD
Carbachol—Sweating—Epirubicin—sarcoma	0.000453	0.00418	CcSEcCtD
Carbachol—Nausea—Thiotepa—sarcoma	0.000444	0.0041	CcSEcCtD
Carbachol—Diarrhoea—Mitoxantrone—sarcoma	0.000442	0.00408	CcSEcCtD
Carbachol—Nausea—Dactinomycin—sarcoma	0.000441	0.00407	CcSEcCtD
Carbachol—Dizziness—Vincristine—sarcoma	0.000439	0.00405	CcSEcCtD
Carbachol—Abdominal pain—Etoposide—sarcoma	0.000425	0.00392	CcSEcCtD
Carbachol—Body temperature increased—Etoposide—sarcoma	0.000425	0.00392	CcSEcCtD
Carbachol—Vomiting—Vincristine—sarcoma	0.000422	0.0039	CcSEcCtD
Carbachol—Sweating—Doxorubicin—sarcoma	0.000419	0.00387	CcSEcCtD
Carbachol—Rash—Vincristine—sarcoma	0.000418	0.00386	CcSEcCtD
Carbachol—Dermatitis—Vincristine—sarcoma	0.000418	0.00386	CcSEcCtD
Carbachol—Headache—Vincristine—sarcoma	0.000415	0.00384	CcSEcCtD
Carbachol—Vomiting—Mitoxantrone—sarcoma	0.000411	0.00379	CcSEcCtD
Carbachol—Rash—Mitoxantrone—sarcoma	0.000407	0.00376	CcSEcCtD
Carbachol—Dermatitis—Mitoxantrone—sarcoma	0.000407	0.00376	CcSEcCtD
Carbachol—Headache—Mitoxantrone—sarcoma	0.000405	0.00374	CcSEcCtD
Carbachol—Nausea—Vincristine—sarcoma	0.000394	0.00364	CcSEcCtD
Carbachol—Flushing—Epirubicin—sarcoma	0.000393	0.00363	CcSEcCtD
Carbachol—Nausea—Mitoxantrone—sarcoma	0.000384	0.00354	CcSEcCtD
Carbachol—Arrhythmia—Epirubicin—sarcoma	0.000379	0.0035	CcSEcCtD
Carbachol—PLA2G4A—tendon—sarcoma	0.000376	0.0447	CbGeAlD
Carbachol—Diarrhoea—Etoposide—sarcoma	0.000368	0.0034	CcSEcCtD
Carbachol—PLA2G4A—bone marrow—sarcoma	0.000364	0.0433	CbGeAlD
Carbachol—Flushing—Doxorubicin—sarcoma	0.000364	0.00336	CcSEcCtD
Carbachol—Flatulence—Epirubicin—sarcoma	0.000364	0.00336	CcSEcCtD
Carbachol—Dizziness—Etoposide—sarcoma	0.000355	0.00328	CcSEcCtD
Carbachol—Muscle spasms—Epirubicin—sarcoma	0.000355	0.00328	CcSEcCtD
Carbachol—Arrhythmia—Doxorubicin—sarcoma	0.00035	0.00324	CcSEcCtD
Carbachol—Vomiting—Etoposide—sarcoma	0.000342	0.00316	CcSEcCtD
Carbachol—Rash—Etoposide—sarcoma	0.000339	0.00313	CcSEcCtD
Carbachol—Dermatitis—Etoposide—sarcoma	0.000338	0.00313	CcSEcCtD
Carbachol—Headache—Etoposide—sarcoma	0.000337	0.00311	CcSEcCtD
Carbachol—Flatulence—Doxorubicin—sarcoma	0.000336	0.00311	CcSEcCtD
Carbachol—Syncope—Epirubicin—sarcoma	0.000331	0.00306	CcSEcCtD
Carbachol—Muscle spasms—Doxorubicin—sarcoma	0.000328	0.00303	CcSEcCtD
Carbachol—Loss of consciousness—Epirubicin—sarcoma	0.000324	0.003	CcSEcCtD
Carbachol—Nausea—Etoposide—sarcoma	0.000319	0.00295	CcSEcCtD
Carbachol—PLA2G4A—testis—sarcoma	0.000311	0.037	CbGeAlD
Carbachol—Syncope—Doxorubicin—sarcoma	0.000306	0.00283	CcSEcCtD
Carbachol—CHRM3—smooth muscle tissue—sarcoma	0.0003	0.0357	CbGeAlD
Carbachol—Loss of consciousness—Doxorubicin—sarcoma	0.0003	0.00277	CcSEcCtD
Carbachol—Infection—Epirubicin—sarcoma	0.000299	0.00276	CcSEcCtD
Carbachol—Shock—Epirubicin—sarcoma	0.000296	0.00274	CcSEcCtD
Carbachol—Hyperhidrosis—Epirubicin—sarcoma	0.000291	0.00269	CcSEcCtD
Carbachol—Hypotension—Epirubicin—sarcoma	0.000281	0.0026	CcSEcCtD
Carbachol—Infection—Doxorubicin—sarcoma	0.000277	0.00256	CcSEcCtD
Carbachol—Shock—Doxorubicin—sarcoma	0.000274	0.00253	CcSEcCtD
Carbachol—Hyperhidrosis—Doxorubicin—sarcoma	0.000269	0.00249	CcSEcCtD
Carbachol—Dyspepsia—Epirubicin—sarcoma	0.000265	0.00245	CcSEcCtD
Carbachol—Hypotension—Doxorubicin—sarcoma	0.00026	0.00241	CcSEcCtD
Carbachol—Pain—Epirubicin—sarcoma	0.000258	0.00238	CcSEcCtD
Carbachol—Dyspepsia—Doxorubicin—sarcoma	0.000245	0.00227	CcSEcCtD
Carbachol—Pain—Doxorubicin—sarcoma	0.000238	0.0022	CcSEcCtD
Carbachol—Body temperature increased—Epirubicin—sarcoma	0.000238	0.0022	CcSEcCtD
Carbachol—Abdominal pain—Epirubicin—sarcoma	0.000238	0.0022	CcSEcCtD
Carbachol—PLA2G4A—lymph node—sarcoma	0.000226	0.0268	CbGeAlD
Carbachol—Abdominal pain—Doxorubicin—sarcoma	0.00022	0.00203	CcSEcCtD
Carbachol—Body temperature increased—Doxorubicin—sarcoma	0.00022	0.00203	CcSEcCtD
Carbachol—Diarrhoea—Epirubicin—sarcoma	0.000206	0.0019	CcSEcCtD
Carbachol—Dizziness—Epirubicin—sarcoma	0.000199	0.00184	CcSEcCtD
Carbachol—Vomiting—Epirubicin—sarcoma	0.000191	0.00177	CcSEcCtD
Carbachol—Diarrhoea—Doxorubicin—sarcoma	0.000191	0.00176	CcSEcCtD
Carbachol—Rash—Epirubicin—sarcoma	0.00019	0.00175	CcSEcCtD
Carbachol—Dermatitis—Epirubicin—sarcoma	0.00019	0.00175	CcSEcCtD
Carbachol—Headache—Epirubicin—sarcoma	0.000189	0.00174	CcSEcCtD
Carbachol—CHRM3—testis—sarcoma	0.000187	0.0222	CbGeAlD
Carbachol—Dizziness—Doxorubicin—sarcoma	0.000184	0.0017	CcSEcCtD
Carbachol—Nausea—Epirubicin—sarcoma	0.000179	0.00165	CcSEcCtD
Carbachol—Vomiting—Doxorubicin—sarcoma	0.000177	0.00164	CcSEcCtD
Carbachol—Rash—Doxorubicin—sarcoma	0.000176	0.00162	CcSEcCtD
Carbachol—Dermatitis—Doxorubicin—sarcoma	0.000176	0.00162	CcSEcCtD
Carbachol—Headache—Doxorubicin—sarcoma	0.000175	0.00161	CcSEcCtD
Carbachol—Nausea—Doxorubicin—sarcoma	0.000166	0.00153	CcSEcCtD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—PLCG1—sarcoma	0.000101	0.0135	CbGpPWpGaD
Carbachol—PLA2G4A—PDGF Pathway—JUN—sarcoma	9.5e-05	0.0126	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	9.47e-05	0.0126	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—EZR—sarcoma	9.16e-05	0.0122	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—EZR—sarcoma	9.13e-05	0.0121	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—EZR—sarcoma	9.04e-05	0.012	CbGpPWpGaD
Carbachol—PLA2G4A—p38 MAPK Signaling Pathway—MYC—sarcoma	8.53e-05	0.0113	CbGpPWpGaD
Carbachol—PLA2G4A—PDGF Pathway—SRC—sarcoma	8.53e-05	0.0113	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—VEGFC—sarcoma	8.16e-05	0.0109	CbGpPWpGaD
Carbachol—PLA2G4A—AGE/RAGE pathway—MMP2—sarcoma	8.08e-05	0.0107	CbGpPWpGaD
Carbachol—PLA2G4A—Opioid Signalling—CREB1—sarcoma	7.36e-05	0.0098	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—PDGFRB—sarcoma	7.16e-05	0.00953	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	6.84e-05	0.0091	CbGpPWpGaD
Carbachol—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	6.71e-05	0.00893	CbGpPWpGaD
Carbachol—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—sarcoma	6.7e-05	0.00891	CbGpPWpGaD
Carbachol—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—JUN—sarcoma	6.65e-05	0.00884	CbGpPWpGaD
Carbachol—PLA2G4A—Endothelins—JUN—sarcoma	6.48e-05	0.00862	CbGpPWpGaD
Carbachol—PLA2G4A—AGE/RAGE pathway—JUN—sarcoma	6.24e-05	0.0083	CbGpPWpGaD
Carbachol—PLA2G4A—PDGF Pathway—HRAS—sarcoma	6e-05	0.00798	CbGpPWpGaD
Carbachol—PLA2G4A—Endothelins—SRC—sarcoma	5.81e-05	0.00773	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—TEK—sarcoma	5.73e-05	0.00762	CbGpPWpGaD
Carbachol—PLA2G4A—AGE/RAGE pathway—SRC—sarcoma	5.6e-05	0.00745	CbGpPWpGaD
Carbachol—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	5.55e-05	0.00739	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—ANGPT2—sarcoma	5.24e-05	0.00697	CbGpPWpGaD
Carbachol—CHRNA2—Transmission across Chemical Synapses—CREB1—sarcoma	5.05e-05	0.00671	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	5.02e-05	0.00669	CbGpPWpGaD
Carbachol—PLA2G4A—AGE/RAGE pathway—EGFR—sarcoma	4.91e-05	0.00653	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—VEGFC—sarcoma	4.21e-05	0.0056	CbGpPWpGaD
Carbachol—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—sarcoma	4.2e-05	0.00558	CbGpPWpGaD
Carbachol—CHRNA2—Transmission across Chemical Synapses—MDM2—sarcoma	4.17e-05	0.00556	CbGpPWpGaD
Carbachol—PLA2G4A—Endothelins—HRAS—sarcoma	4.09e-05	0.00544	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—CREB1—sarcoma	3.87e-05	0.00514	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—JUN—sarcoma	3.74e-05	0.00498	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—PDGFRB—sarcoma	3.74e-05	0.00498	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—PDGFRB—sarcoma	3.73e-05	0.00496	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	3.71e-05	0.00493	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—PDGFRB—sarcoma	3.69e-05	0.00491	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—PDGFRA—sarcoma	3.68e-05	0.0049	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—PDGFRA—sarcoma	3.67e-05	0.00489	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—PDGFRA—sarcoma	3.64e-05	0.00484	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—CXCR4—sarcoma	3.48e-05	0.00463	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—SRC—sarcoma	3.36e-05	0.00447	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—PLCG1—sarcoma	3.3e-05	0.0044	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	3.27e-05	0.00435	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	3.26e-05	0.00434	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—NRAS—sarcoma	3.23e-05	0.0043	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	3.23e-05	0.0043	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—MDM2—sarcoma	3.2e-05	0.00426	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	3.07e-05	0.00408	CbGpPWpGaD
Carbachol—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	3.05e-05	0.00405	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—MYC—sarcoma	3.01e-05	0.004	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	2.8e-05	0.00373	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	2.79e-05	0.00372	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—KRAS—sarcoma	2.78e-05	0.0037	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	2.77e-05	0.00368	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	2.67e-05	0.00356	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	2.67e-05	0.00355	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	2.65e-05	0.00352	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—CREB1—sarcoma	2.59e-05	0.00344	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—IL2—sarcoma	2.44e-05	0.00325	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	2.39e-05	0.00318	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—HRAS—sarcoma	2.36e-05	0.00314	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	2.33e-05	0.0031	CbGpPWpGaD
Carbachol—CHRNA2—Transmission across Chemical Synapses—HRAS—sarcoma	2.29e-05	0.00305	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	2.14e-05	0.00285	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—CREB1—sarcoma	2.14e-05	0.00285	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—CXCR4—sarcoma	2.13e-05	0.00284	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—SRC—sarcoma	2.13e-05	0.00283	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—CXCR4—sarcoma	2.13e-05	0.00283	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—CXCR4—sarcoma	2.11e-05	0.0028	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	2.1e-05	0.00279	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—sarcoma	2.07e-05	0.00276	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—sarcoma	2.03e-05	0.0027	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—sarcoma	2.02e-05	0.00269	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.98e-05	0.00264	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—JUN—sarcoma	1.86e-05	0.00248	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—CTNNB1—sarcoma	1.85e-05	0.00246	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CXCR4—sarcoma	1.82e-05	0.00242	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.76e-05	0.00234	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—HRAS—sarcoma	1.76e-05	0.00234	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TLE1—sarcoma	1.69e-05	0.00225	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—NRAS—sarcoma	1.69e-05	0.00224	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—NRAS—sarcoma	1.68e-05	0.00224	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—NRAS—sarcoma	1.67e-05	0.00222	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—VEGFA—sarcoma	1.62e-05	0.00216	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ENO2—sarcoma	1.58e-05	0.0021	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—HBA1—sarcoma	1.57e-05	0.00209	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—JUN—sarcoma	1.54e-05	0.00205	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—EGFR—sarcoma	1.54e-05	0.00205	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—EGFR—sarcoma	1.53e-05	0.00204	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—EGFR—sarcoma	1.52e-05	0.00202	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—KRAS—sarcoma	1.45e-05	0.00193	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—KRAS—sarcoma	1.45e-05	0.00193	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—KRAS—sarcoma	1.43e-05	0.00191	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—VEGFC—sarcoma	1.43e-05	0.0019	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PLCG1—sarcoma	1.34e-05	0.00178	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	1.26e-05	0.00167	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—IL2—sarcoma	1.26e-05	0.00167	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	1.25e-05	0.00167	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CXCR4—sarcoma	1.21e-05	0.0016	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CXCR4—sarcoma	1.2e-05	0.0016	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CXCR4—sarcoma	1.19e-05	0.00158	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	1.15e-05	0.00153	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	1.14e-05	0.00152	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—FLT1—sarcoma	1.14e-05	0.00152	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PLCG1—sarcoma	1.12e-05	0.00149	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—SRC—sarcoma	1.1e-05	0.00146	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CXCR4—sarcoma	1.1e-05	0.00146	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CXCR4—sarcoma	1.09e-05	0.00145	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	1.08e-05	0.00144	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CXCR4—sarcoma	1.08e-05	0.00144	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	1.08e-05	0.00144	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CXCR4—sarcoma	1.08e-05	0.00143	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—VEGFA—sarcoma	1.07e-05	0.00142	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ATF1—sarcoma	1.06e-05	0.00142	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—NRAS—sarcoma	1.06e-05	0.0014	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TLE1—sarcoma	1.02e-05	0.00135	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—TP53—sarcoma	1.02e-05	0.00135	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TLE1—sarcoma	1.01e-05	0.00135	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TLE1—sarcoma	1e-05	0.00133	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CREB1—sarcoma	9.76e-06	0.0013	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ENO2—sarcoma	9.46e-06	0.00126	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—HBA1—sarcoma	9.4e-06	0.00125	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	9.2e-06	0.00122	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	9.17e-06	0.00122	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—KRAS—sarcoma	9.08e-06	0.00121	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—VEGFC—sarcoma	8.57e-06	0.00114	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—VEGFC—sarcoma	8.54e-06	0.00114	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—VEGFC—sarcoma	8.46e-06	0.00113	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IGF1R—sarcoma	8.35e-06	0.00111	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—TP53—sarcoma	8.07e-06	0.00107	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PLCG1—sarcoma	8.03e-06	0.00107	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—FOXO1—sarcoma	7.95e-06	0.00106	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PDGFRB—sarcoma	7.94e-06	0.00106	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PDGFRA—sarcoma	7.81e-06	0.00104	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—HRAS—sarcoma	7.72e-06	0.00103	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL2—sarcoma	7.22e-06	0.00096	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FLT1—sarcoma	6.85e-06	0.000912	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FLT1—sarcoma	6.83e-06	0.000909	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FLT1—sarcoma	6.76e-06	0.0009	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PLCG1—sarcoma	6.73e-06	0.000896	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PLCG1—sarcoma	6.71e-06	0.000893	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PLCG1—sarcoma	6.65e-06	0.000884	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—KDR—sarcoma	6.58e-06	0.000875	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CXCR4—sarcoma	6.47e-06	0.000861	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CXCR4—sarcoma	6.45e-06	0.000858	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ATF1—sarcoma	6.4e-06	0.000851	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CXCR4—sarcoma	6.39e-06	0.00085	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ATF1—sarcoma	6.38e-06	0.000848	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ATF1—sarcoma	6.31e-06	0.00084	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—KIT—sarcoma	6.06e-06	0.000806	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—NRAS—sarcoma	6.06e-06	0.000806	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CREB1—sarcoma	5.87e-06	0.000781	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CREB1—sarcoma	5.85e-06	0.000778	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CREB1—sarcoma	5.79e-06	0.000771	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CREB1—sarcoma	5.77e-06	0.000767	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—EGFR—sarcoma	5.52e-06	0.000734	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—KRAS—sarcoma	5.21e-06	0.000694	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IGF1R—sarcoma	5.02e-06	0.000668	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IGF1R—sarcoma	5e-06	0.000666	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IGF1R—sarcoma	4.95e-06	0.000659	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FOXO1—sarcoma	4.78e-06	0.000636	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—IL2—sarcoma	4.78e-06	0.000635	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MDM2—sarcoma	4.77e-06	0.000635	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PDGFRB—sarcoma	4.77e-06	0.000635	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FOXO1—sarcoma	4.76e-06	0.000634	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—IL2—sarcoma	4.76e-06	0.000633	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PDGFRB—sarcoma	4.75e-06	0.000633	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FOXO1—sarcoma	4.72e-06	0.000628	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—IL2—sarcoma	4.71e-06	0.000627	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PDGFRB—sarcoma	4.71e-06	0.000626	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PDGFRA—sarcoma	4.69e-06	0.000625	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PDGFRA—sarcoma	4.68e-06	0.000623	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PDGFRA—sarcoma	4.63e-06	0.000617	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—HRAS—sarcoma	4.43e-06	0.00059	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL2—sarcoma	4.34e-06	0.000577	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL2—sarcoma	4.32e-06	0.000575	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL2—sarcoma	4.28e-06	0.00057	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL2—sarcoma	4.26e-06	0.000567	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCND1—sarcoma	4.16e-06	0.000553	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—JUN—sarcoma	4.15e-06	0.000552	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CTNNB1—sarcoma	4.11e-06	0.000548	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KDR—sarcoma	3.95e-06	0.000526	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KDR—sarcoma	3.94e-06	0.000524	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KDR—sarcoma	3.9e-06	0.000519	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SRC—sarcoma	3.72e-06	0.000495	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KIT—sarcoma	3.64e-06	0.000484	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—NRAS—sarcoma	3.64e-06	0.000484	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KIT—sarcoma	3.63e-06	0.000483	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—NRAS—sarcoma	3.63e-06	0.000483	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—VEGFA—sarcoma	3.62e-06	0.000482	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KIT—sarcoma	3.59e-06	0.000478	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—NRAS—sarcoma	3.59e-06	0.000478	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NRAS—sarcoma	3.58e-06	0.000476	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CREB1—sarcoma	3.47e-06	0.000461	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CREB1—sarcoma	3.45e-06	0.00046	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CREB1—sarcoma	3.42e-06	0.000455	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MYC—sarcoma	3.33e-06	0.000444	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—EGFR—sarcoma	3.32e-06	0.000441	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—EGFR—sarcoma	3.31e-06	0.00044	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—EGFR—sarcoma	3.27e-06	0.000436	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—EGFR—sarcoma	3.26e-06	0.000434	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—KRAS—sarcoma	3.13e-06	0.000417	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—KRAS—sarcoma	3.12e-06	0.000416	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—KRAS—sarcoma	3.09e-06	0.000412	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—KRAS—sarcoma	3.08e-06	0.00041	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MDM2—sarcoma	2.87e-06	0.000382	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MDM2—sarcoma	2.86e-06	0.00038	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MDM2—sarcoma	2.83e-06	0.000377	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TP53—sarcoma	2.74e-06	0.000364	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—HRAS—sarcoma	2.66e-06	0.000354	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—HRAS—sarcoma	2.65e-06	0.000353	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—HRAS—sarcoma	2.63e-06	0.00035	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HRAS—sarcoma	2.62e-06	0.000348	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL2—sarcoma	2.56e-06	0.000341	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL2—sarcoma	2.55e-06	0.00034	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL2—sarcoma	2.53e-06	0.000337	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCND1—sarcoma	2.5e-06	0.000332	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—JUN—sarcoma	2.49e-06	0.000332	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCND1—sarcoma	2.49e-06	0.000331	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—JUN—sarcoma	2.48e-06	0.000331	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CTNNB1—sarcoma	2.47e-06	0.000329	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCND1—sarcoma	2.47e-06	0.000328	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CTNNB1—sarcoma	2.47e-06	0.000328	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—JUN—sarcoma	2.46e-06	0.000327	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CTNNB1—sarcoma	2.44e-06	0.000325	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SRC—sarcoma	2.24e-06	0.000297	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SRC—sarcoma	2.23e-06	0.000297	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SRC—sarcoma	2.21e-06	0.000294	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—VEGFA—sarcoma	2.18e-06	0.00029	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—VEGFA—sarcoma	2.17e-06	0.000289	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NRAS—sarcoma	2.15e-06	0.000286	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—VEGFA—sarcoma	2.15e-06	0.000286	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NRAS—sarcoma	2.14e-06	0.000285	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NRAS—sarcoma	2.12e-06	0.000282	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MYC—sarcoma	2e-06	0.000267	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MYC—sarcoma	2e-06	0.000266	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MYC—sarcoma	1.98e-06	0.000263	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EGFR—sarcoma	1.96e-06	0.000261	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EGFR—sarcoma	1.95e-06	0.00026	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EGFR—sarcoma	1.93e-06	0.000257	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KRAS—sarcoma	1.85e-06	0.000246	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KRAS—sarcoma	1.84e-06	0.000246	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KRAS—sarcoma	1.83e-06	0.000243	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TP53—sarcoma	1.64e-06	0.000219	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TP53—sarcoma	1.64e-06	0.000218	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TP53—sarcoma	1.62e-06	0.000216	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HRAS—sarcoma	1.57e-06	0.000209	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HRAS—sarcoma	1.57e-06	0.000209	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HRAS—sarcoma	1.55e-06	0.000207	CbGpPWpGaD
